Politico August 9, 2025
By David Lim

Vinay Prasad had been dismissed less than two weeks ago.

Dr. Vinay Prasad is back at the FDA less than two weeks after the White House pressed the head of the agency to remove him from his multiple agency leadership roles, an HHS spokesperson said Saturday.

After Commissioner Marty Makary requested the return of Prasad to his job regulating biologics and vaccines, the White House decided the agency could bring him back after reviewing Prasad’s past remarks highlighted by right-wing provocateur Laura Loomer last month, according to a person familiar with the decision granted anonymity to discuss the decision.

“At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article